NCT04708054 2026-02-19
Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
M.D. Anderson Cancer Center
Phase 2/3 Recruiting
Clinical Trials
8 trialsNCT03870750 2026-01-12
Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases
Fred Hutchinson Cancer Center
Phase 2/3 Terminated
NCT00177047 2021-11-09
Autologous Transplant for Multiple Myeloma
Masonic Cancer Center, University of Minnesota
Phase 2/3 Completed
NCT01588951 2018-08-14
Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2/3 Terminated
NCT00176839 2017-12-05
Stem Cell Transplantation for Hematological Malignancies
Masonic Cancer Center, University of Minnesota
Phase 2/3 Terminated
NCT01015742 2012-06-04
Unrelated Double Umbilical Cord Blood Units Transplantation
Tehran University of Medical Sciences
Phase 2/3 Unknown
NCT00966810 2009-08-27
Allogeneic Stem Cell Transplantation in CML With Partial T Cell Depletion
Rambam Health Care Campus
Phase 2/3 Unknown
NCT00382759 2009-08-03
Nonmyeloablative Stem Cell Transplant in Elderly
Azienda Ospedaliera San Giovanni Battista
Phase 2/3 Completed